Eun Yang
Stock Analyst at Jefferies
(0)
# 4836
Out of 5,243 analysts
71
Total ratings
34.78%
Success rate
-25.93%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
United Therapeutics | Maintains: Strong Buy | 315 432 | 361.62 | 19.46% | 7 | Sep 23, 2024 | |
Aerovate Therapeutic... | Downgrades: Hold | 65 2 | 2.47 | -19.03% | 3 | Jun 17, 2024 | |
Taysha Gene Therapie... | Assumes: Buy | 2 8 | 1.62 | 393.83% | 2 | May 14, 2024 | |
Deciphera Pharmaceut... | Downgrades: Hold | 26 26 | n/a | n/a | 1 | Apr 29, 2024 | |
Astria Therapeutics | Maintains: Strong Buy | 22 27 | 7.77 | 247.49% | 2 | Mar 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 7 2 | 0.92 | 63.04% | 2 | Feb 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 170 18 | n/a | n/a | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 24 33 | 34.98 | -5.66% | 1 | Jul 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 36 28 | 4.06 | 589.66% | 2 | Jun 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 27 | 22.64 | 19.26% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 6 7 | 2.69 | 160.22% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 49 42 | n/a | n/a | 2 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 17 7 | n/a | n/a | 3 | Dec 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 2.87 | 771.08% | 1 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 525 75 | 1.1 | 6718.18% | 1 | Sep 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 78 84 | 104.77 | -19.82% | 3 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 25 | 1.47 | 1600.68% | 1 | Nov 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | n/a | n/a | n/a | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 15.44 | 126.68% | 1 | Jun 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 38 | n/a | n/a | 3 | Mar 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 14 5 | n/a | n/a | 2 | May 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Hold | 13 6 | n/a | n/a | 3 | Jan 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 160 | n/a | n/a | 4 | Oct 15, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 200 220 | 269.05 | -18.23% | 3 | Jul 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | n/a | n/a | n/a | 1 | Jan 23, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 38 31 | 11.6 | 167.24% | 4 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 26 25 | n/a | n/a | 4 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 30 | n/a | n/a | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 400 | 2.11 | 18857.35% | 1 | Jul 24, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 310 | 140.95 | 119.94% | 3 | Jul 11, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Hold | 80 | 92.3 | -13.33% | 3 | Jul 11, 2017 |